The Next Generation of Life Science Audit | Deloitte US has been added to your bookmarks.
Perspectives
Audit evolved
The next generation of life sciences audit
Running a life sciences business has never been more challenging. Life sciences (LS) companies face pricing pressures as health care reform puts a laser focus on patient outcomes and measurable results. Is the complex mix of market forces a major threat or an opportunity? At Deloitte, we see it as part of the evolution of life sciences—and we are evolving with it.
Download the brochure
The life sciences brochure will provide you with:
- An overview of disruptive industry forces and issues
- Statistics on Deloitte’s LS industry team and practice
- Audit as an opportunity, innovation, and more
Disrupting the norm
Powerful market forces in life sciences are influencing how companies compete and grow. Six key trends appear to be shaping the industry.
Audit evolved. At Deloitte, audit is more than an obligation for our clients—it’s an opportunity.
Get in touch
Recommendations
2018 Life Sciences Accounting and Financial Reporting Update
Insights on new accounting standards and more
Life Sciences Industry Outlook 2017
What are the trends for US life sciences in the coming year?